We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ANALYST SEES SILVER LINING IN MEDICARE REIMBURSEMENT CHANGE
ANALYST SEES SILVER LINING IN MEDICARE REIMBURSEMENT CHANGE
August 3, 2004
Fears that changing the formula for calculating reimbursements for Rx drugs through Medicare will significantly reduce the volume of cancer drugs prescribed for patients are probably exaggerated, according to a drug industry analyst.